Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.
Global Dermatophytic Onychomycosis Treatment market is projected to reach US$ 2014.6 million in 2029, increasing from US$ 1201.2 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dermatophytic Onychomycosis Treatment market research.
Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dermatophytic Onychomycosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc
Segment by Type
Systemic Therapy
Topical Therapy
Others
Segment by Application
Hospitals
Dermatology Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dermatophytic Onychomycosis Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Related Reports:
Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Systemic Therapy
1.2.3 Topical Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Dermatophytic Onychomycosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Treatment Market Perspective (2018-2029)
2.2 Dermatophytic Onychomycosis Treatment Growth Trends by Region
2.2.1 Global Dermatophytic Onychomycosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermatophytic Onychomycosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Dermatophytic Onychomycosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Dermatophytic Onychomycosis Treatment Market Dynamics
2.3.1 Dermatophytic Onychomycosis Treatment Industry Trends
2.3.2 Dermatophytic Onychomycosis Treatment Market Drivers
2.3.3 Dermatophytic Onychomycosis Treatment Market Challenges
2.3.4 Dermatophytic Onychomycosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue
3.1.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Dermatophytic Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Treatment Revenue
3.4 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio
3.4.1 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Treatment Revenue in 2022
3.5 Dermatophytic Onychomycosis Treatment Key Players Head office and Area Served
3.6 Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
3.7 Date of Enter into Dermatophytic Onychomycosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatophytic Onychomycosis Treatment Breakdown Data by Type
4.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2024-2029)
5 Dermatophytic Onychomycosis Treatment Breakdown Data by Application
5.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dermatophytic Onychomycosis Treatment Market Size (2018-2029)
6.2 North America Dermatophytic Onychomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023)
6.4 North America Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatophytic Onychomycosis Treatment Market Size (2018-2029)
7.2 Europe Dermatophytic Onychomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023)
7.4 Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatophytic Onychomycosis Treatment Market Size (2018-2029)
9.2 Latin America Dermatophytic Onychomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Detail
11.1.2 Bausch Health Companies Business Overview
11.1.3 Bausch Health Companies Dermatophytic Onychomycosis Treatment Introduction
11.1.4 Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.1.5 Bausch Health Companies Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Dermatophytic Onychomycosis Treatment Introduction
11.2.4 Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Detail
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Dermatophytic Onychomycosis Treatment Introduction
11.3.4 Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.3.5 Johnson and Johnson Recent Development
11.4 Galderma S.A.
11.4.1 Galderma S.A. Company Detail
11.4.2 Galderma S.A. Business Overview
11.4.3 Galderma S.A. Dermatophytic Onychomycosis Treatment Introduction
11.4.4 Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.4.5 Galderma S.A. Recent Development
11.5 Celtic Pharmaceuticals
11.5.1 Celtic Pharmaceuticals Company Detail
11.5.2 Celtic Pharmaceuticals Business Overview
11.5.3 Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
11.5.4 Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.5.5 Celtic Pharmaceuticals Recent Development
11.6 Anacor Pharmaceuticals
11.6.1 Anacor Pharmaceuticals Company Detail
11.6.2 Anacor Pharmaceuticals Business Overview
11.6.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
11.6.4 Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.6.5 Anacor Pharmaceuticals Recent Development
11.7 Moberg Pharma AB
11.7.1 Moberg Pharma AB Company Detail
11.7.2 Moberg Pharma AB Business Overview
11.7.3 Moberg Pharma AB Dermatophytic Onychomycosis Treatment Introduction
11.7.4 Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.7.5 Moberg Pharma AB Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Dermatophytic Onychomycosis Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Pfizer Inc
11.9.1 Pfizer Inc Company Detail
11.9.2 Pfizer Inc Business Overview
11.9.3 Pfizer Inc Dermatophytic Onychomycosis Treatment Introduction
11.9.4 Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023)
11.9.5 Pfizer Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Systemic Therapy
Table 3. Key Players of Topical Therapy
Table 4. Key Players of Others
Table 5. Global Dermatophytic Onychomycosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dermatophytic Onychomycosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Dermatophytic Onychomycosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Dermatophytic Onychomycosis Treatment Market Share by Region (2018-2023)
Table 9. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Dermatophytic Onychomycosis Treatment Market Share by Region (2024-2029)
Table 11. Dermatophytic Onychomycosis Treatment Market Trends
Table 12. Dermatophytic Onychomycosis Treatment Market Drivers
Table 13. Dermatophytic Onychomycosis Treatment Market Challenges
Table 14. Dermatophytic Onychomycosis Treatment Market Restraints
Table 15. Global Dermatophytic Onychomycosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Dermatophytic Onychomycosis Treatment Market Share by Players (2018-2023)
Table 17. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2022)
Table 18. Ranking of Global Top Dermatophytic Onychomycosis Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
Table 22. Date of Enter into Dermatophytic Onychomycosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dermatophytic Onychomycosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Dermatophytic Onychomycosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Bausch Health Companies Company Detail
Table 48. Bausch Health Companies Business Overview
Table 49. Bausch Health Companies Dermatophytic Onychomycosis Treatment Product
Table 50. Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 51. Bausch Health Companies Recent Development
Table 52. Novartis AG Company Detail
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Dermatophytic Onychomycosis Treatment Product
Table 55. Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Johnson and Johnson Company Detail
Table 58. Johnson and Johnson Business Overview
Table 59. Johnson and Johnson Dermatophytic Onychomycosis Treatment Product
Table 60. Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 61. Johnson and Johnson Recent Development
Table 62. Galderma S.A. Company Detail
Table 63. Galderma S.A. Business Overview
Table 64. Galderma S.A. Dermatophytic Onychomycosis Treatment Product
Table 65. Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 66. Galderma S.A. Recent Development
Table 67. Celtic Pharmaceuticals Company Detail
Table 68. Celtic Pharmaceuticals Business Overview
Table 69. Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
Table 70. Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 71. Celtic Pharmaceuticals Recent Development
Table 72. Anacor Pharmaceuticals Company Detail
Table 73. Anacor Pharmaceuticals Business Overview
Table 74. Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Product
Table 75. Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 76. Anacor Pharmaceuticals Recent Development
Table 77. Moberg Pharma AB Company Detail
Table 78. Moberg Pharma AB Business Overview
Table 79. Moberg Pharma AB Dermatophytic Onychomycosis Treatment Product
Table 80. Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 81. Moberg Pharma AB Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Dermatophytic Onychomycosis Treatment Product
Table 85. GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Pfizer Inc Company Detail
Table 88. Pfizer Inc Business Overview
Table 89. Pfizer Inc Dermatophytic Onychomycosis Treatment Product
Table 90. Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2018-2023) & (US$ Million)
Table 91. Pfizer Inc Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytic Onychomycosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dermatophytic Onychomycosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Systemic Therapy Features
Figure 4. Topical Therapy Features
Figure 5. Others Features
Figure 6. Global Dermatophytic Onychomycosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Dermatology Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Dermatophytic Onychomycosis Treatment Report Years Considered
Figure 12. Global Dermatophytic Onychomycosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Dermatophytic Onychomycosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Dermatophytic Onychomycosis Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Dermatophytic Onychomycosis Treatment Market Share by Players in 2022
Figure 16. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Treatment Revenue in 2022
Figure 18. North America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Dermatophytic Onychomycosis Treatment Market Share by Country (2018-2029)
Figure 20. United States Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Dermatophytic Onychomycosis Treatment Market Share by Country (2018-2029)
Figure 24. Germany Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Share by Region (2018-2029)
Figure 32. China Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Dermatophytic Onychomycosis Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Dermatophytic Onychomycosis Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Bausch Health Companies Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 47. Novartis AG Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 48. Johnson and Johnson Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 49. Galderma S.A. Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 50. Celtic Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 51. Anacor Pharmaceuticals Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 52. Moberg Pharma AB Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 54. Pfizer Inc Revenue Growth Rate in Dermatophytic Onychomycosis Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.